Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Adenoma”

266 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 266 results

Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableStudy completedNCT06557408
What this trial is testing

Pancreatic Fistula After Minimally Invasive Enucleation

Who this might be right for
Pancreatic Tumor, BenignPancreatic Neuroendocrine TumorSolid Pseudopapillary Tumor of the Pancreas
Fudan University 173
Not applicableStudy completedNCT01401907
What this trial is testing

Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies

Who this might be right for
Non-small Cell Lung CancerSmall Cell Lung CancerMesothelioma+4 more
Massachusetts General Hospital 351
Large-scale testing (Phase 3)Looking for participantsNCT06881992
What this trial is testing

Ersodetug in Patients With Tumor Hyperinsulinism

Who this might be right for
Tumor Hyperinsulinism (Tumor HI)
Rezolute 16
Early research (Phase 1)Looking for participantsNCT06663072
What this trial is testing

Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Pancreatic Neuroendocrine Tumor
University of Chicago 25
Early research (Phase 1)Ended earlyNCT05571839
What this trial is testing

PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerColorectal Neoplasms+2 more
Seagen, a wholly owned subsidiary of Pfizer 41
Not applicableAvailableNCT01916148
What this trial is testing

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Who this might be right for
Congenital Hyperinsulinism (CHI)Beckwith-Wiedemann SyndromeInsulinoma
Children's Hospital of Philadelphia
Not applicableUnknownNCT05448157
What this trial is testing

68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET

Who this might be right for
Neuroendocrine Tumor CarcinoidNeuroendocrine Tumor of PancreasGep Net
European Institute of Oncology 20
Early research (Phase 1)Study completedNCT02355535
What this trial is testing

Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1

Who this might be right for
Solid TumorPancreatic Neuroendocrine TumorNeuroendocrine Tumors
Vanquish Oncology, Inc. 48
Early research (Phase 1)Study completedNCT01204476
What this trial is testing

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

Who this might be right for
Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more
National Cancer Institute (NCI) 27
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Not applicableUnknownNCT04709445
What this trial is testing

Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses

Who this might be right for
Bowel ObstructionBowel IschemiaDiverticulitis+9 more
Charite University, Berlin, Germany 100
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Not applicableNot Yet RecruitingNCT06167421
What this trial is testing

Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy

Who this might be right for
Pancreatic Tumor, BenignPancreatic Neuroendocrine TumorSolid Pseudopapillary Tumor of the Pancreas
Fudan University 240
Testing effectiveness (Phase 2)UnknownNCT02758587
What this trial is testing

Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)

Who this might be right for
Carcinoma, Non-small-cell LungMesotheliomaPancreatic Neoplasms
NHS Greater Glasgow and Clyde 59
Not applicableLooking for participantsNCT04115254
What this trial is testing

Stereotactic Magnetic Resonance Guided Radiation Therapy

Who this might be right for
Pancreas CancerLung CancerRenal Cancer+10 more
Dana-Farber Cancer Institute 397
Not applicableUnknownNCT03033186
What this trial is testing

Everolimus TDM to Predict Long Term Toxicity

Who this might be right for
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more
Maastricht University Medical Center 40
Next Page